High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

American Heart Journal

Volumn 161, Issue 5, 2011, Pages 993-999

  Schwartz, Gregory G ^a,e   Chaitman, Bernard R ^b   Goldberger, Jeffrey J ^c   Messig, Michael ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d PFIZER INC   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; PLACEBO;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CHOLESTEROL; CHRONIC DISEASE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PYRROLES; RETROSPECTIVE STUDIES; STROKE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955918190     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.02.002     Document Type: Article

References (44)

1. Go A.S., Hylek E.M., and Phillips K.A. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375 (Pubitemid 32424106)
2. Greenlee R.T., and Vidaillet H. Recent progress in the epidemiology of atrial fibrillation Curr Opin Cardiol 20 2005 7 14 (Pubitemid 40030304)
3. Issac T.T., Dokainish H., and Lakkis N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J Am Coll Cardiol 50 2007 2021 2028 (Pubitemid 350087568)
4. Kourliouros A., Savelieva I., and Kiotsekoglou A. Current concepts in the pathogenesis of atrial fibrillation Am Heart J 157 2009 243 252
5. Ridker P.M., Danielson E., and Fonseca F.A. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
6. Tsai C.T., Lai L.P., and Kuo K.T. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling Circulation 117 2008 344 355
7. Shiroshita-Takeshita A., Brundel B.J., and Burstein B. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure Cardiovasc Res 74 2007 75 84 (Pubitemid 46366949)
8. Adam O., Frost G., and Custodis F. Role of Rac1 GTPase activation in atrial fibrillation J Am Coll Cardiol 50 2007 359 367 (Pubitemid 47064499)
9. Kumagai K., Nakashima H., and Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model Cardiovasc Res 62 2004 105 111 (Pubitemid 38326816)
10. Adabag A.S., Nelson D.B., and Bloomfield H.E. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure Am Heart J 154 2007 1140 1145 (Pubitemid 350116030)
11. Pellegrini C.N., Vittinghoff E., and Lin F. Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial Heart 95 2009 704 708
12. Ramani G., Zahid M., and Good C.B. Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome Am J Cardiol 100 2007 404 405 (Pubitemid 47094684)
13. Young-Xu Y., Jabbour S., and Goldberg R. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease Am J Cardiol 92 2003 1379 1383 (Pubitemid 37532555)
14. Hanna I.R., Heeke B., and Bush H. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction Heart Rhythm 3 2006 881 886 (Pubitemid 44103516)
15. Amar D., Zhang H., and Heerdt P.M. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein Chest 128 2005 3421 3427 (Pubitemid 41698673)
16. Virani S.S., Nambi V., and Razavi M. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery Am Heart J 155 2008 541 546
17. Ozaydin M., Dogan A., and Varol E. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation Cardiology 107 2007 117 121
18. Mithani S., Akbar M.S., and Johnson D.J. Dose dependent effect of statins on postoperative atrial fibrillation after cardiac surgery among patients treated with beta blockers J Cardiothorac Surg 4 2009 61
19. Miceli A., Fino C., and Fiorani B. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting Ann Thorac Surg 87 2009 1853 1858
20. Mariscalco G., Lorusso R., and Klersy C. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery Ann Thorac Surg 84 2007 1158 1164 (Pubitemid 47417886)
21. Marin F., Pascual D.A., and Roldan V. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting Am J Cardiol 97 2006 55 60 (Pubitemid 41828123)
22. Lertsburapa K., White C.M., and Kluger J. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery J Thorac Cardiovasc Surg 135 2008 405 411 (Pubitemid 351192943)
23. Humphries K.H., Lee M., and Sheldon R. Statin use and recurrence of atrial fibrillation after successful cardioversion Am Heart J 154 2007 908 913 (Pubitemid 350010927)
24. Ozaydin M., Varol E., and Aslan S.M. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion Am J Cardiol 97 2006 1490 1493
25. Siu C.W., Lau C.P., and Tse H.F. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion Am J Cardiol 92 2003 1343 1345
26. Amit G., Katz A., and Bar-On S. Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker Clin Cardiol 29 2006 249 252 (Pubitemid 43865703)
27. Ji Q., Mei Y., and Wang X. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting Circ J 73 2009 2244 2249
28. Patti G., Chello M., and Candura D. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study Circulation 114 2006 1455 1461 (Pubitemid 44526999)
29. Almroth H., Hoglund N., and Boman K. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study Eur Heart J 30 2009 827 833
30. Tveit A., Grundtvig M., and Gundersen T. Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion Am J Cardiol 93 2004 780 782 (Pubitemid 38338579)
31. Maggioni A.P., Fabbri G., and Lucci D. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial Eur Heart J 30 2009 2327 2336
32. Marini C., De S.F., and Sacco S. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study Stroke 36 2005 1115 1119 (Pubitemid 40803473)
33. Amarenco P., Bogousslavsky J., and Callahan A.S. High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 2006 549 559 (Pubitemid 44202151)
34. Amarenco P., Bogousslavsky J., and Callahan A.S. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study Cerebrovasc Dis 16 2003 389 395
35. Fauchier L., Pierre B., and de L.A. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials J Am Coll Cardiol 51 2008 828 835 (Pubitemid 351255618)
36. Adam O., Neuberger H.R., and Bohm M. Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Circulation 118 2008 1285 1293
37. G.G. Schwartz, B. Chaitman, and J. Goldberger Effect of intensive statin treatment on the occurrence of atrial fibrillation after acute coronary syndrome: an analysis of the MIRACL trial Circulation 110 Suppl III 2004 III 740
38. Lavallee P.C., Labreuche J., and Gongora-Rivera F. Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease Stroke 40 2009 1721 1728
39. Evans S. When and how can endpoints be changed after initiation of a randomized clinical trial? PLoS Clin Trials 2 2007 e18
40. Kourliouros A., De S.A., and Roberts N. Dose-related effect of statins on atrial fibrillation after cardiac surgery Ann Thorac Surg 85 2008 1515 1520 (Pubitemid 351618357)
41. McLean D.S., Ravid S., and Blazing M. Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials Am Heart J 155 2008 298 302
42. Goldberger J.J., Subacius H., and Schaechter A. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy J Am Coll Cardiol 48 2006 1228 1233 (Pubitemid 44363151)
43. Mitchell L.B., Powell J.L., and Gillis A.M. Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics versus Implantable Defibrillators (AVID) trial J Am Coll Cardiol 42 2003 81 87 (Pubitemid 36760765)
44. Amarenco P., Goldstein L.B., and Sillesen H. Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial Stroke 41 2010 426 430